What is Science Lab?
Science Lab operates as a specialized manufacturer and formulator of premium lubricants and health supplements, anchored by its flagship Swiss Navy and BioXGenic brands. With a legacy spanning over two decades, the organization has established itself as a cornerstone in the wellness industry, providing both branded solutions and comprehensive private label manufacturing services. By maintaining all production facilities within the United States, Science Lab ensures rigorous quality control and regulatory compliance, which serves as a key differentiator in a market increasingly focused on product integrity and safety.
The company's business model is built upon a dual-track approach: fostering brand equity through its proprietary product lines while simultaneously acting as a reliable manufacturing partner for other enterprises. This versatility allows Science Lab to capture significant market share across diverse distribution channels, ranging from retail health outlets to specialized wellness platforms.
How much funding has Science Lab raised?
Science Lab has raised a total of $786K across 2 funding rounds:
Debt
$350K
Debt
$436K
Debt (2020): $350K with participation from PPP
Debt (2021): $436K led by PPP
Key Investors in Science Lab
PPP
Public-Private Partnership
What's next for Science Lab?
Looking ahead, Science Lab is positioned to leverage its recent capital to further refine its supply chain and accelerate product innovation. The strategic focus will likely shift toward enhancing manufacturing efficiency and exploring new market segments within the broader health and wellness ecosystem. By prioritizing operational excellence and maintaining its commitment to domestic production, the company is well-equipped to navigate shifting consumer preferences and regulatory landscapes.
The integration of these funds will be critical in scaling production capacity to meet the rising demand for high-quality wellness products. As the firm continues to evolve, its ability to balance brand development with private label manufacturing will remain a central pillar of its long-term growth strategy, ensuring sustained relevance in an increasingly crowded marketplace.
